Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2010
12/01/2010CN101319971B Preparation method of paraffin organization chip
12/01/2010CN101319008B Polypeptide having specific combination with neoplasm metastasis cell and uses thereof
12/01/2010CN101303289B High pressure solid clay pervasion test device
12/01/2010CN101293917B Polypeptide combinative with PKR kinase structure field specificity and uses thereof
12/01/2010CN101173314B Reagent kit for detecting senility macular degeneration disease
12/01/2010CN101131382B System and method for testing performance of thin-film material under electricity/heat/force coupling action
12/01/2010CN101131363B Yeast triple-hybridization based small molecule compound detecting method
12/01/2010CN101118213B Method for detecting adulteration of dextrinin and raw milk
12/01/2010CN101115990B Semiconductor device
12/01/2010CN101085812B SARS coronavirus polypeptide antigen and application thereof
12/01/2010CN101078720B Improved reagent and method for classifying leucocyte
12/01/2010CN101051023B Detecting reagent and detecting method
12/01/2010CN101035907B Method for detecting streptococcus agalactiae using esterase activity
11/2010
11/30/2010US7844940 Mask set for microarray, method of fabricating mask set, and method of fabricating microarray using mask set
11/30/2010US7844431 Method and apparatus for integrated modeling, simulation and analysis of chemical and biochemical reactions
11/30/2010US7844403 Temperature step correction with double sigmoid Levenberg-Marquardt and robust linear regression
11/30/2010US7843567 Methods of identifying an analyte and nucleic acid analysis
11/30/2010US7843562 Detection of biomolecules using porous biosensors and Raman spectroscopy
11/30/2010US7843555 Thermoplastic plastic and method for producing the same
11/30/2010US7842916 Method of and apparatus for analyzing ions adsorbed on surface of mask
11/30/2010US7842823 utilize a boronate deprotection mechanism to provide high selectivity and optical dynamic range for detecting H2O2 in aqueous solution over similar reactive oxygen species (ROS) including superoxide, nitric oxide, tert-butyl hydroperoxide, and hydroxyl radical; bioassays for cellular H2O2 pathology
11/30/2010US7842811 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA
11/30/2010US7842797 Human CDR-grafted antibody and antibody fragment thereof
11/30/2010US7842795 Nucleic acids encoding a heme binding protein polypeptide
11/30/2010US7842786 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1
11/30/2010US7842785 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
11/30/2010US7842782 Heparanase-derived peptides for vaccination of tumor patients
11/30/2010US7842649 Quality control method for making a biochip displaying an encoded bead array
11/30/2010US7842517 rapid and sensitive detection of post-translationally modified proteins; exploits mutant of beta-1,4-galactosyltransferase to selectively transfer unnatural ketone functionality, for attaching biotin; detecting cancer, Alzheimer's disease, neurodegeneration, cardiovascular disease, and diabetes
11/30/2010US7842516 Detectable labels, methods of manufacture and use
11/30/2010US7842515 Nano-structured device for analysis or separation, and its preparation and application
11/30/2010US7842514 Channeled fractionation apparatus for separating, capturing and detecting proteins
11/30/2010US7842513 Preparing immunoglobulin for use as tool in immunoassay for determining pregnancy in ruminants; animal husbandry; in vito fertilization; veterinary medicine
11/30/2010US7842512 Dyed microspheres for characterization of photochemical reactor behavior
11/30/2010US7842511 Colorimetric monitoring of reactions in solution and solid phase automated and manual systems
11/30/2010US7842510 A specific measuring solution is added to the compost to flocculate a compost extract containing humic-like substance and decomposed organic matter, a liquid phase is acquired by precipitating the compost extract by the solid/liquid separation, measuring the maturity degree from color contrasting density
11/30/2010US7842507 spectrophotometry; by ultraviolet absorbance spectroscopy; conjugate measurements of carbonate and pH can then be used to calculate all carbon system parameters of interest, including the total concentration of dissolved inorganic carbon in seawater
11/30/2010US7842506 includes a blood test that measures an Apo E genotype from the patient to generate Apo B information; using the information as data tool in designing physical regimen to prevent and/or alleviate cardiovascular disorders
11/30/2010US7842505 Fluorescent labeling reagent
11/30/2010US7842500 Anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
11/30/2010US7842498 Substrated having an adsorbent layer attached to the surface of a water-swellable hydrogel with hydrophobic moieties and hydrophilic moieties; binds an analyte through a salt-independent hydrophobic attraction.
11/30/2010US7842491 composition comprising an apo-carbonic anhydrase protein and a photoluminescent molecule selected from 4-(2-hydroxyethylthio)-7-aminosulfonyl-2,1,3-benzoxadiazole and hydroxynaphthalenesulphonamide 2; homogeneous fluorescence polarization (anisotropy) assays; detecting and quantifying ions in solution
11/30/2010US7842478 DNA encoding mammalian phosphodiesterases
11/30/2010US7842475 a dry assay reagent, which comprises a solid support and one or more molecules of a receptor immobilized on the solid support; bioassay
11/30/2010US7842474 for determining whether an animal is naturally-infected with Ehrlichia canis, or is either not infected or is vaccinated with an E. canis vaccine
11/30/2010US7842473 for determining whether an animal is naturally-infected with Ehrlichia canis, or is either not infected or is vaccinated with an E. canis vaccine
11/30/2010US7842472 Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
11/30/2010US7842471 provides a biosensor including a transfected cell that express various receptors and ion channels that are used in a bio-signal transmitter detection, such as a sniffer-patch method, for achieving efficient detection; highly sensitive
11/30/2010US7842470 Method for pharmacoperones correction of GnRHR mutant protein misfolding
11/30/2010US7842469 Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof
11/30/2010US7842468 Using concentration of N-methyl D-asparate-associated (NMDA) glutamate receptors in tissue as evaluative tool in detection of neuroendocrine cancers; diagnosing small cell lung cancer (SCLC) or breast cancer
11/30/2010US7842467 detecting an elevated level of NPC2 protein in a breast sample; peptides and protein differentially expressed in breast cancer (BCAT)
11/30/2010US7842466 detecting an elevated level of CD-MPR protein in a colon sample; molecular biomarker; cancer
11/30/2010US7842465 Immunocytostaining methods for enhanced dye ratio discrimination in rare event detection
11/30/2010US7842464 diagnosing a pregnant woman at increased risk of preeclampsia; HELLP (hemolysis, elevated liver enzymes; contacting the sample with an antibody that specifically binds a marker
11/30/2010US7842463 Method of diagnosing early stage renal impairment
11/30/2010US7842461 determining whether the subject's B-CLL cells have been clonally expanded from post-GC B cells (post-germinal center memory B-cells) or pre-GC B cells (pre-germinal center B cells); cancer
11/30/2010US7842460 using a Ubiquitin or Ubiquitin-like Protein and a signal producing structure; evaluating and/or screening compounds for their effects on the enzyme activity, detecting activity in samples; useful for the diagnosis of conditions and diseases associated with altered enzyme levels, amounts, sequences
11/30/2010US7842458 Amino acid sequences for use in diagnosis, prevention and detection of cancer
11/30/2010US7842456 detecting and/or quantifying molecules expressing selected epitope using antibodies linked to nucleic acid templates suitable for use in RNA amplification application whereby the amplification product is stained with a fluorescent dye in order to detect and quantify ; profiling proteins in a cell lysate
11/30/2010US7842453 Methods of identifying modulators of ChemerinR polypeptides
11/30/2010US7842298 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand
11/30/2010US7842297 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient
11/30/2010US7842294 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits
11/30/2010US7842290 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms
11/30/2010US7842245 Fluid handling unit and fluid handling apparatus using same
11/30/2010US7842244 means for jetting gas into system to separate fluid samples for the analysis of multiple samples consisting of multiple cells or particles in a rapid manner
11/30/2010US7842240 Microchip for analysis, analysis system having the same, and analysis method
11/30/2010US7842234 Diagnostic devices incorporating fluidics and methods of manufacture
11/30/2010US7842175 Electrophoresis
11/30/2010US7842157 upper and lower substrates are bonded via organic solvent between; microarrays
11/30/2010US7841992 Tissue penetration device
11/30/2010US7841824 Method for transferring magnetic samples from a source to a target
11/30/2010US7841265 Method for cutting off glass panes from a continuously produced glass sheet
11/30/2010CA2601153C Breath test simulator
11/30/2010CA2573787C Method and apparatus for applying fluids to a biological sample
11/30/2010CA2530052C System and method for analyte measurement using dose sufficiency electrodes
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2425365C Method for determining the rheology of a gelled fluid
11/30/2010CA2414524C Assaying method
11/30/2010CA2408455C Gas sensor calibration system
11/30/2010CA2396255C Method and apparatus for analysing acid gas loading within an amine solution
11/30/2010CA2383135C Method of identifying properties of substance with respect to human prostaglandin d2 receptors
11/30/2010CA2373109C Ready to use spackle/repair product containing dryness indicator
11/30/2010CA2365565C Detection methods
11/30/2010CA2350947C Filter bag
11/30/2010CA2322202C Detection and characterization of microorganisms
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/30/2010CA2217053C Method of photochemical immobilization of ligands using quinones
11/30/2010CA2189740C Transgenic arthritic mice
11/30/2010CA2144328C Improved method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
11/25/2010WO2010135717A2 Complement assays and uses thereof
11/25/2010WO2010135704A2 Secretion-related bacterial proteins for nlrc4 stimulation
11/25/2010WO2010135682A1 New biomarkers for liver injury
11/25/2010WO2010135671A1 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy
11/25/2010WO2010135663A2 Compositions and methods for the detection of hiv-1/hiv-2 infection
11/25/2010WO2010135646A1 Usability features for integrated insulin delivery system
11/25/2010WO2010135603A2 Method for cancer detection, diagnosis and prognosis
11/25/2010WO2010135574A2 Systems and methods for determining the percentage of glycated hemoglobin
11/25/2010WO2010135555A1 Method for determining the cardio-generative potential of mammalian cells
1 ... 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 ... 3937